# Levothyroxine Sodium

NDC: 42292-040
Generic name: levothyroxine sodium
Labeler / Manufacturer: Mylan Institutional Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20170119

FDA application: ANDA076187

## Active ingredients

- LEVOTHYROXINE SODIUM: 175 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"42292-040"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=42292-040
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd69c192-cd3f-47e6-b0a6-c536ffed5c4b